Manuscripts
Showing 1533 manuscripts.
Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children
Citation
D Jacobson, PACTG 219/219c, GK Siberry, H Li. Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children. AIDS. 2014. 28: 247-250. PMID: 22471877Year
2014
Journal
AIDS
Study
1077HS, 1077BF
A Sensitive HPLC-MS/MS Method for the Determination of Dolutegravir in Human Plasma
Citation
P Savina, EP Acosta, C Bennetto-Hood, G Tabolt. A Sensitive HPLC-MS/MS Method for the Determination of Dolutegravir in Human Plasma. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences. 2014. 225-232. PMID: 24361860Year
2014
Journal
Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences
Study
P1093
Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection
Citation
George R. Seage III, Murli R Purswani, Hans M.L. Spiegel, Gaston Zilleruelo, Carolyn Abibol, Barbara Heckman, Christopher B Ponce, James M Oleske, Charles D Mitchell, Miriam C. Chernoff. Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection. Pediatric Nephrology. 2014. 30: 153-165. PMID: 25149850Year
2014
Journal
Pediatric Nephrology
Associations of Host Genetic Variants on CD4+ Lymphocyte Count and Plasma HIV-1 RNA in Antiretroviral Naïve Children.
Citation
Singh KK, Fenton T, Apector SA, Qin M, Brummel S. Associations of Host Genetic Variants on CD4+ Lymphocyte Count and Plasma HIV-1 RNA in Antiretroviral Naïve Children.. Pediaric Infectious Disease Journal. 2014. 33: 946-952. PMID: 2797997Year
2014
Journal
Pediaric Infectious Disease Journal
HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-blood Compartments from HIV-1-Infected Men and Women Enrolled in AIDS Clinical Trials Group Study A5077.
Citation
RJ Bosch, M Mann, D Katzenstein, S Cu-Uvin, R D'Aquila, L Frenkel, S Fiscus, R Coombs, ACTG A5077 Study Team, R Kantor, D Bettendorf. HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-blood Compartments from HIV-1-Infected Men and Women Enrolled in AIDS Clinical Trials Group Study A5077.. PLoS One. 2014. 9: e93537. PMID: 24699474Year
2014
Journal
PLoS One
HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
Citation
A Garg, SA Spector. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.. Journal of Infectious Diseases. 2014. 209: 441-451. PMID: 23999600Year
2014
Journal
Journal of Infectious Diseases
Are infants unique in their ability to be "functionally cured" of HIV-1
Citation
NH Tobin, GM Aldrovandi. Are infants unique in their ability to be "functionally cured" of HIV-1. Current HIV/AIDS Reports. 2014. 11: 1-10. PMID: 24390641Year
2014
Journal
Current HIV/AIDS Reports
Pharmacokinetic Enhancers in HIV Therapeutics
Citation
C Delille, I Otofokun, EP Acosta, KB Larson, K Wang. Pharmacokinetic Enhancers in HIV Therapeutics. Clinical Pharmacokinetics. 2014. 53: 865-872. PMID: 25164142Year
2014
Journal
Clinical Pharmacokinetics
Pharmacokinetics, Safety, and 48-Week Efficacy
of Oral Raltegravir in HIV-1–Infected Children
Aged 2 Through 18 Years
Citation
Edward P Acosta, Hedy Teppler, Brenda Homony, Bobbie Graham, Terence Fenton, Xia Xu, Larissa Wenning, Stephen A Spector, Lisa M Frenkel, Carmelita Alvero, Carol Worrell, Edward Handelsman, Andrew Winzia, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1066 Study Team, Sharon Nachman, Nan Zheng. Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1–Infected Children Aged 2 Through 18 Years. Clinical Infectious Diseases. 2014. 58: 413-422. PMID: 24145879Year
2014
Journal
Clinical Infectious Diseases
Study
P1066